DEVELOPMENT OF FIVE-MEMBER HETEROCYCLIC COMPOUNDS AS POTENTIAL NAV 1.7 INHIBITORS Authors: Sonavane S , BIRAJDAR M.J., SATPUTE K.L., MANKE M.B, GIRAM P.S. AND BHUSNURE O.G.
ABSTRACT
Pain is often defined as a single form of the nervous system for abnormal things in the human
body. Neuropathic pain (NP) is a kind of pain that is a worry of nerve damage and usually, it
is a chronic type. Sodium Channel 1.7 (Nav 1.7) is an forthcoming biological target against
neuropathic pain management. Several heterocyclic compounds are reported for potentials
against neuropathic pain. 10 different heterocyclic derivatives from thiadiazole class were
synthesized,virtually analyzed against Nav 1.7 for inhibition potential and carry out biological
activity by Streptozotocine (STZ) induced diabetic pain model. The developed thiadiazole were
confirmed via spectral analysis and showed excellent binding ability with Nav 1.7, which can
be further sightseen for biological activity.
Keywords: Pain, Neuropathic pain, Thiadiazole, Docking, STZ Publication date: 01/09/2024 https://ijbpas.com/pdf/2024/September/MS_IJBPAS_2024_8323.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2024/13.9.8323